Global Plaque Psoriasis Treatment Market Report and Forecast 2024-2032

Global Plaque Psoriasis Treatment Market Outlook

The growth of the global plaque psoriasis treatment market size is being driven by the rising prevalence of the condition across the globe. The number of worldwide cases in 2023 was close to 128.64 million. The prevalence of the condition is anticipated to grow at a CAGR of 3% during the forecast period of 2024-2032, likely to reach 167.84 cases by 2032.

Plaque Psoriasis Treatment Market: Introduction

Psoriasis refers to a skin condition which leads to red, inflamed, raised, and itchy skin on different parts of the body. The condition has various types and plaque psoriasis is one of the most common types, affecting more than 8 million Americans every year. About 90% of psoriasis patients suffer from plaque psoriasis, making it the most prevalent type of the condition. Plaque psoriasis is an auto-immune chronic disorder in which the production of new skin cells becomes extremely fast. While the production of new skin cells normally takes place in 28-30 days, the production speeds up and the new skin cells start developing within 3 to 4 days. The replacement of old skin cells with new ones results in the production of plaques over the skin. The increased prevalence of the condition is providing significant impetus to the growth of the plaque psoriasis treatment market.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Plaque psoriasis leads to severe red patches or plaques all over the skin, with thick whitish scales which are made of dead skin cells. These scales can occur throughout the body and/or on parts of the body which are mostly dehydrated, like scalp, elbows, lower back, knees, among others. Patients with severe condition also experience these scales on their face, feet, hands, legs, and even genitals, if not controlled timely. These patches are extremely problematic since it causes severe itchiness and even hurts, and the burning sensation can become intense and worse with time. It even becomes difficult for the patient to wear clothes over these patches, leading to perennial discomfort.

As discussed above, the most common symptoms of the condition mostly include scaly patches on the skin, which can painful and irritating. As the condition aggravates, the symptoms can intensify to crack (fissures) in skin and even bleeding in some cases.

The auto-immune disorder does not have a cure yet, but the available treatments are effective and can help relieve the symptoms to some extent, if followed regularly. The exact cause of the disease is not known yet, but genetic factors and immune system play a pivotal role in the development of this condition. Other diseases like Crohn's disease, fatty liver disease, diabetes, and metabolic syndrome can also lead to this skin condition.

Plaque Psoriasis Treatment Market- Epidemiology

Plaque psoriasis mostly happens due to genetic factors, it usually runs in the family. This skin condition can happen to anyone, irrespective of their age or sex, however, if affects some more than the others. People belonging to western regions are more vulnerable to this condition than the others.

The possibility of suffering from plaque psoriasis is also significantly dependent on the lifestyle of an individual. Consumption of alcohol, smoke, and other tobacco-based products can increase the chances of suffering from this disorder. Moreover, being obese can also increase a person’s vulnerability to the condition. Having depression or stress can also worsen this condition, since that mostly leads to the irregularity in the consumption of medicines and lack of self-care. The condition can also be caused due to triggers like reaction of some medicines or severe sunburn.

Plaque Psoriasis Treatment Market Segmentations

The market can be categorised into diagnosis method, treatment type, therapy type, route of administration, drug type, population type, treatment channel, end user, distribution channel, and major regions.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Diagnosis Method

• Blood Tests
• Skin Prick Test
• Patch Test
• Biopsy 
• Others

Plaque Psoriasis Treatment Market Breakup by Treatment Type

• Biologics Drugs
  • Apremilast
  • Atanercept
  • Infliximab
  • Adalimumab
  • Ustekinumab
  • Secukinumab
  • Ixekizumab
  • Guselkumab
  • Tildrakizumab
  • Certolizumab
  • Others
• Systemic Drugs
  • Methotrexate
  • Soriatane
  • Otezla
  • Sotyktu
  • Cyclosporin
  • Others
• Phototherapy
  • Ultraviolet B (UVB)
• Topical Drugs
  • Calcipotriene
  • Tazarotene
  • Calcineurin Inhibitors
  • Roflumilast
  • Salicylic Acid
  • Others
• Others

Market Breakup by Therapy Type

• Monotherapy
• Combination Therapy

Market Breakup by Route of Administration

• Oral
• Tablets
• Capsules
• Parentals
• Intravenous
• Intramuscular
• Topicals
• Others

Plaque Psoriasis Treatment Market Breakup by Drug Type

• Over the Counter
• Prescription
• Branded
• Generics

Market Breakup by Population Type

• Children
• Adults
• Male 
• Female
• Geriatrics
• Male 
• Female

Market Breakup by Treatment Channel

• Public
• Private

Market Breakup by End User

• Hospitals
• Specialty Clinics
• Homecare Settings
• Others

Market Breakup by Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Plaque Psoriasis Treatment Market Breakup by Region

• North America
  • United States of America 
  • Canada
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Plaque Psoriasis Treatment Market- Therapeutic Landscape

The treatments currently available in the plaque psoriasis treatment market can only help in relieving and controlling the symptoms and do not guarantee complete cure from the disease. These treatments must be regularly followed to be effective. If the patient does not follow the regime regularly, then it might not help in managing the symptoms.

• Biological Drugs- These drugs are given via a shot or through a vein in the arm. Biological drugs help in targeting some immune cells and restrict the proteins from causing further inflammation. While these drugs help in relieving the symptoms of plaque psoriasis, these can severely affect the capability of the immune system to fight infections. The most popular biological drugs used in the treatment market include Apremilast, Atanercept, Infliximab, Adalimumab, Ustekinumab, Secukinumab, Ixekizumab, Guselkumab, Tildrakizumab, and Certolizumab, among others.

• Systemic Drugs- These drugs are preferred in the case of severe condition. Systemic drugs work throughout the body and calm the immune system. It also controls the growth of new skin cells, leading to reduced inflammation. The most prominent systemic drugs circulating in the market are Methotrexate, Soriatane, Otezla, Sotyktu, and Cyclosporin, among others. These drugs are quite effective, however, the consumption of these drugs can also cause severe side effects. Some side effects include higher risk of skin cancer, liver disorders, and aggressive thoughts and/or depression, among others.

• Topical Drugs- If the patient is experiencing the initial stage of plaque psoriasis, with just a few patches, then the dermatologist might suggest some topical treatment. These prescription creams, gels, or ointments can be applied directly to the affected area for the prescribed period of time. These can include a combination of exfoliating treatments, with moisturising creams, to get rid of the dead skin and to keep the flaky skin at bay. The dermatologist suggests the treatment on the basis of the severity of the condition. They can either prescribe these drugs to be used individually or in combination. The most common topical drugs prescribed for this condition include Calcipotriene, Tazarotene, Calcineurin Inhibitors, Roflumilast, and Salicylic Acid, among others.

• Phototherapy- Phototherapy, also known as light therapy, is also used to reduce the inflammation and slow down the production of new skin cells in psoriasis patients. This treatment is preferred for patients experiencing mild to severe symptoms, or if they have not responded to any other treatment method. In this method, the affected skin is treated with ultraviolet light, which can help reduce the inflammation and can even clear up the patches completely. The treatment is extremely beneficial but can even increase the risk of developing skin cancer amongst psoriasis patients.

While these treatments can help relieve the symptoms, it is always better to follow preventive measures to avoid worsening the condition further. The patients can practise a healthy diet and regular skin care regime to avoid further damage, along with regular consultation with their doctors.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Plaque Psoriasis Treatment Market Scenario

The demand for the treatment market is rapidly rising with the rising number of cases across the globe. Changing lifestyles of people, along with the rising addiction to tobacco-based products, cigarettes, and alcohol, has increased their risk of suffering from this condition. Rising number of obese people is also contributing to the rising prevalence of the disease, especially in North America.

North America is leading the global market with a significant share. While in the developing region, the awareness about the condition is pretty low, developed regions are taking initiatives to boost the awareness about the condition. For instance, August is celebrated as Psoriasis Awareness Month in the United States every year. During this month, the government aims to provide support to those who are affected by this condition and spread awareness about the condition. Such initiatives are leading to higher people opting for diagnosis when they experience any symptom similar symptoms, which results in early detection and timely treatment.

Apart from North America, Europe is also witnessing higher growth due to the rising prevalence of the disease. In the Asia Pacific region, leading countries like Australia and India are also witnessing fast growth due to the rising awareness about the condition and its treatment, aided by government support. Such measures are significantly aiding the growth of the market.

Key Players in the Global Plaque Psoriasis Treatment Market

The major companies working on the drugs and treatment of the condition and investing in the clinical trials include the following:

• Pfizer Inc.
• Abbvie Inc.
• Novartis AG
• Amgen Inc.
• Boehringer Ingelheim International GmbH.
• Merck & Co Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals Industries Ltd. 
• AstraZeneca
• Ampio Pharmaceuticals Inc.
• Eli Lilly and Company
• Novartis International AG
• Sun Pharmaceuticals Industries Ltd.
• Stiefel Laboratories
• UCB S.A.
• LEO Pharma
• Cipla Inc.
• Rowan Bioceuticals
• Glenmark Pharmaceuticals
• Win-Medicare Pvt. Ltd.
• Sanofi S.A.

Key Highlights of the Report